Alison Moore, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 17,396 shares at $7.63 ($133K) on 2022-03-15, disclosed to the SEC on 2022-03-17.
Seasonal sale ($133k) by Chief Technical Officer — this insider has traded ALLO in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.63 | 8,698 | $66K | 50.0% |
| 2 | $7.63 | 8,698 | $66K | 50.0% |
| Total | $7.63 avg | 17,396 | $133K | 100% |
| Filing → |
| CDXS | SELL | 2025-10-15 | $16K | — | Filing → |
| ALLO | SELL | 2021-03-17 | $470K | — | Filing → |
| ALLO | SELL | 2020-10-13 | $1.5M | — | Filing → |